Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAltitude Group Regulatory News (ALT)

Share Price Information for Altitude Group (ALT)

Share Price is delayed by 15 minutes
Get Live Data
20.50    0.50 (2.50%)
Bid:
20.00
Ask:
21.00
Spread: 1.00 (5.00%)
Market Cap: £14.99m
ALT Live PriceLast checked at - London Stock Exchange

Intraday Altitude Group Share Chart

Director/PDMR Dealing

9 Apr 2026 12:00

RNS Number : 8569Z
Altitude Group PLC
09 April 2026
 

9 April 2026

 

 

Altitude Group plc

("Altitude" or the "Company")

 

Director/PDMR Dealing

 

Altitude Group plc (AIM: ALT), a technology and services provider specialising in end-to-end solutions for the branded merchandise and promotional products industry, announces the following dealings made by a director in its ordinary shares of 0.4p each ("Ordinary Shares").

 

Bob Wigley, Non-Executive Director, purchased 200,000 Ordinary Shares at an average price of 22.325 pence per share. Following the purchase of Ordinary Shares, Bob Wigley's beneficial holding is 200,000 Ordinary Shares, representing approximately 0.27% of the Company's issued share capital.

 

For further information, please contact:

 

Altitude Group plc

Alexander Brennan, Executive Chair

Drew Whibley, Chief Financial Officer

Deborah Wilkinson, Chief Operating Officer

Via Singer Capital Markets

 

 

Singer Capital Markets

Tel: +44 (0) 20 7496 3000

James Moat / James Fischer / Carl Diebitsch

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Bob Wigley

2.

Reason for the notification

a.

Position/status

Non-Executive Director

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Altitude Group plc

b.

LEI

213800VACSTYYSI39R89

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Shares of 0.4p each

 

GB00B0LSFV82

b.

Nature of the transaction

Purchase of Ordinary Shares

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

21.25p

23.40p

100,000

100,000

d.

Aggregated information

· Aggregated volume

· Price

 

 

200,000 Ordinary Shares

 

22.325p per Ordinary Share

e.

Date of the transaction

2 April 2026

8 April 2026

f.

Place of the transaction

London Stock Exchange, AIMX

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHILMMTMTAMBFF
Date   Source Headline
8th May 20177:00 amRNSChange of Adviser and Notice of Results Update
19th Apr 20177:00 amRNSNew Supply Agreements and Notice of Results
3rd Apr 20177:00 amRNSAppointment of Managing Director
14th Feb 20177:00 amRNSTrading Update
8th Feb 20173:05 pmRNSIssue of Options
6th Feb 20179:30 amRNSHolding(s) in Company
31st Jan 201711:30 amRNSHolding(s) in Company
31st Jan 20179:41 amRNSHolding(s) in Company
30th Jan 20174:14 pmRNSIssue of Equity
25th Jan 201712:22 pmRNSBoard and Management changes
25th Jan 20177:00 amRNSCompany Presentation
16th Jan 20177:00 amRNSCompany Presentation on 25 January 2017
30th Nov 20167:00 amRNSDirector/PDMR Shareholding
18th Nov 20167:00 amRNSExercise of Options and PDMR Shareholdings
15th Nov 20167:00 amRNSFirst "Click to Ship" (C2S) Web Sites Launched
1st Nov 201612:00 pmRNSHolding(s) in Company
27th Oct 20165:03 pmRNSHolding(s) in Company
12th Oct 20167:00 amRNSIssue of Equity & Director/PDMR Shareholdings
3rd Oct 201611:20 amRNSStatement re Share Price Movement
27th Sep 20163:13 pmRNSHolding(s) in Company
26th Sep 20168:51 amRNSDirector/PDMR Shareholding
20th Sep 20167:00 amRNSHalf-year Report
14th Sep 20161:05 pmRNSHolding(s) in Company
12th Aug 20167:00 amRNSDirector/PDMR Shareholding
12th Aug 20167:00 amRNSHolding(s) in Company
5th Aug 201610:49 amRNSTechnology Partnership Agreement
1st Aug 20169:50 amRNSDirector/PDMR Shareholding
29th Jul 201611:23 amRNSDirector/PDMR Shareholding
22nd Jul 20167:00 amRNSGrant of Options
15th Jul 20162:14 pmRNSTrading Update & Retention of Exhibitions Business
6th Jul 201612:17 pmRNSResult of AGM
28th Jun 20167:00 amRNSAddress of AGM
14th Jun 20167:12 amRNSEnterprise Level Technology Agreement
10th Jun 20164:43 pmRNSAnnual Report and Accounts
20th May 20167:00 amRNSFinal Results
15th Apr 201611:32 amRNSStatement re. Share Price Movement
7th Apr 201610:53 amRNSHolding(s) in Company
14th Jan 20167:00 amRNSBoard Reorganisation and Update
1st Oct 20157:00 amRNSIntegration Agreement with Constant Contact
29th Sep 20158:49 amRNSInterim Results - Replacement
29th Sep 20157:00 amRNSInterim Results
17th Aug 20157:00 amRNSIssue of US Patent
7th Jul 20157:00 amRNSGrant of Options
2nd Jul 20157:00 amRNSDirector/PDMR Shareholding
1st Jul 20157:00 amRNSDirector/PDMR Shareholding
30th Jun 20152:12 pmRNSResult of AGM
30th Jun 20157:00 amRNSAGM Statement
24th Jun 20157:00 amRNSAddress of AGM
16th Jun 201510:22 amRNSDirector/PDMR Shareholding - Correction
15th Jun 20151:38 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.